this is a study evaluating the efficacy and safety of a infliximab biosimilar CT-P13 in the treatment of patients with psoriasis. Data were collected fromt the Psobiosimilar registry.
Infliximab biosimilar CT-P13 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry
Gisondi, P;SAVOIA, FRANCESCA;Girolomoni, G.
2017-01-01
Abstract
this is a study evaluating the efficacy and safety of a infliximab biosimilar CT-P13 in the treatment of patients with psoriasis. Data were collected fromt the Psobiosimilar registry.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Gisondi Infliximab CT-P13 psoriasis BJD 2017.pdf
non disponibili
Tipologia:
Documento in Post-print
Licenza:
Accesso ristretto
Dimensione
123.73 kB
Formato
Adobe PDF
|
123.73 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
